Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) Sees Large Drop in Short Interest

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) was the target of a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 1,600 shares, a decrease of 97.5% from the January 31st total of 65,000 shares. Based on an average daily volume of 440,900 shares, the short-interest ratio is currently 0.0 days.

Daiichi Sankyo Price Performance

Daiichi Sankyo stock traded up $0.56 during mid-day trading on Thursday, hitting $23.58. The company’s stock had a trading volume of 211,780 shares, compared to its average volume of 227,494. Daiichi Sankyo has a twelve month low of $22.47 and a twelve month high of $42.48. The stock’s fifty day moving average price is $26.32 and its two-hundred day moving average price is $31.27. The stock has a market capitalization of $45.00 billion and a P/E ratio of 27.42. The company has a quick ratio of 2.11, a current ratio of 2.77 and a debt-to-equity ratio of 0.06.

Daiichi Sankyo (OTCMKTS:DSNKY) last announced its earnings results on Friday, January 31st. The company reported $0.22 earnings per share (EPS) for the quarter. Daiichi Sankyo had a return on equity of 14.53% and a net margin of 13.62%. Research analysts forecast that Daiichi Sankyo will post 0.73 earnings per share for the current year.

Daiichi Sankyo Company Profile

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.